Circulating neutrophils from cancer patients and TANs can also uptake low-density lipoproteins (LDL) via lectin-type oxidized LDL receptor-1 (LOX-1) with direct implications in tumor progression [170]. The gene discussed is OLR1; the disease is neoplasm.